Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 25, 2025
Accession Number:
0001193125-25-060215
Submission Type:
POS AM
CIK:
0001850838
Company Name:
Omega Therapeutics, Inc.
File Number:
333-268254